Literature DB >> 12165800

Gain of Xq detected by comparative genomic hybridization in elastofibroma.

Jun Nishio Nishio1, Hiroshi Iwasaki, Yuko Ohjimi, Masako Ishiguro, Takamasa Koga, Teruto Isayama, Masatoshi Naito, Masahiro Kikuchi.   

Abstract

Elastofibroma is a rare, benign, slow-growing degenerative pseudotumor that typically occurs in the subscapular region and has been considered a peculiar fibroblastic proliferation with accumulation of abnormal elastic fibers. Very little is known about the cytogenetic and molecular genetic changes in elastofibroma. In the present study, we analyzed DNA copy number changes in 27 elastofibromas by comparative genomic hybridization. DNA was extracted from 22 archival paraffin-embedded tumor tissues and from 5 fresh frozen samples. Nine (33%) of the 27 cases exhibited DNA copy number changes involving one or two chromosomes, whereas the remaining 18 cases exhibited no DNA copy number changes. The majority of the changes were gains (8 cases), whereas 2 cases showed losses. The most common recurrent gains were at chromosomal locations Xq12-q22 (6 cases) and 19 (2 cases). High-level amplifications and recurrent losses were not observed. There was no correlation between DNA copy number changes and the pseudotumor size. The present study has identified a chromosomal region that may contain genes involved in the development of at least some elastofibromas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165800

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

1.  High-resolution genome-wide analysis of chromosomal alterations in elastofibroma.

Authors:  Juan Luis García Hernández; Javier Ortiz Rodríguez-Parets; José María Valero; María Asunción Gomez Muñoz; M Rocío Benito; Jesus M Hernandez; Agustín Bullón
Journal:  Virchows Arch       Date:  2010-04-27       Impact factor: 4.064

2.  Retrospective analysis of 73 cases of elastofibroma.

Authors:  R Haihua; W Xiaobing; P Jie; H Xinxin
Journal:  Ann R Coll Surg Engl       Date:  2019-06-24       Impact factor: 1.891

3.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

4.  Elastofibroma: clonal fibrous proliferation with predominant CD34-positive cells.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

Review 5.  Elastofibroma of the gluteal region with a concomitant contralateral lesion: case report and review of the literature.

Authors:  Luca Cevolani; R Casadei; D Vanel; M Gambarotti; D Donati
Journal:  Skeletal Radiol       Date:  2017-01-05       Impact factor: 2.199

6.  Upregulation of TGF-β1 and basic FGF in elastofibroma: an immunohistochemical analysis.

Authors:  Akiko Imanishi; Hisayoshi Imanishi; Yasuhiko Yoshida; Aya Okabayashi; Chiharu Tateishi; Hirofumi Ikushima; Ren Nagasako; Koichi Nakagawa; Daisuke Tsuruta
Journal:  Med Mol Morphol       Date:  2015-11-09       Impact factor: 2.309

7.  Elastofibroma dorsi: a histochemical and immunohistochemical study.

Authors:  A Di Vito; E Scali; G Ferraro; C Mignogna; I Presta; C Camastra; G Donato; T Barni
Journal:  Eur J Histochem       Date:  2015-02-19       Impact factor: 3.188

8.  Elastofibroma dorsi: Clinical evaluation of 61 cases and review of the literature.

Authors:  Mehmet Ali Deveci; Hilmi Serdar Özbarlas; Kıvılcım Eren Erdoğan; Ömer Sunkar Biçer; Mustafa Tekin; Cenk Özkan
Journal:  Acta Orthop Traumatol Turc       Date:  2016-10-22       Impact factor: 1.511

9.  Elastofibroma: clinical results after resection of a rare tumor entity.

Authors:  Hakan Pilge; Tobias Hesper; Boris Michael Holzapfel; Peter Michael Prodinger; Melanie Straub; Rüdiger Krauspe
Journal:  Orthop Rev (Pavia)       Date:  2014-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.